Research Grants 5 show all


$270.8K
2003

$99.9K
2009

$149.9K
2011

$500K
2012

Patents 735show all

  • 273
    A61K - Preparations for medical, dental, or toilet purposes
  • 228
    C07C - Acyclic or carbocyclic compounds
  • 124
    C07D - Heterocyclic compounds
  • 104
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 49
    C01B - Non-metallic elements
  • 49
    Y02A - Technologies for adaptation to climate change
  • 34
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry
  • 29
    B01F - Mixing, e.g. dissolving, emulsifying, dispersing
  • 28
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 27
    C07B - General methods of organic chemistry

Clinical Trials 15show all

8Phase 24N/A3Phase 3

SEC Filings show all


6
D

Contact Information

Memphis, TN
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-02-16$8,000,000$4,493,115Other
2011-12-08$8,000,000$2,993,115Other
2011-11-08$8,000,000$2,349,999Other
2011-07-28$8,000,000$1,999,999Other
2010-05-10$4,000,000$4,000,000Other
2008-07-23Unknown Unknown Other (Paper Filing)

Key Executives

  • Eric McFarland
    Executive Officer, Director
  • Sally Irving
    Executive Officer
  • Thomas Hook
    Director
  • Don Ingram
    Director
  • Raymond Brickey
    Director
  • K. Leonard Judson
    Director